Olawande Funmilola Adebayo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Olawande Funmilola Adebayo has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Babatunde Olamide Bamgbose
Aminu Kano Teaching Hospital, Zaria Road, Kano 700233, Kano State, Nigeria
1 shared publication - Dada Oluwaseyi Temilola
International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town 7925, South Africa
1 shared publication - Fadekemi Olufunmilayo Oginni
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Obafemi Awolowo University, Ile-Ife, Nigeria
1 shared publication - Foluso John Owotade
Department of Oral Medicine and Oral Pathology, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife 220282, Nigeria
1 shared publication - Manogari Chetty
Craniofacial Biology, Pathology, and Radiology Department, Faculty of Dentistry University of the Western Cape Cape Town South Africa
1 shared publication - Mohammad Abubakar Kaura
Department of Family Dentistry, Faculty of Dentistry, Bayero University Kano, Kano, Nigeria
1 shared publication
Latest Publications
- Open Access
- 30 March 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (7) , 1044
Clinical Utility of Small Extracellular Vesicles as Liquid Biopsy for Oral Mucosal Disease Diagnostics: Emerging Perspectives
Some diseases affecting the oral mucosa can be life-threatening and/or associated with life-threatening complications. Conventional diagnostic methods for most oral mucosal diseases are usually employed at a fully established disease state. All these peculiarities usually result in late diagnosis, poor prognosis, poor treatment outcomes, and reduced overall survival rates, hence the need for novel methods for the early detection of these disease conditions. Small extracellular vesicle (sEV)-based diagnosis carries great potential for early diagnosis of oral mucosal diseases, as sEVs reflect the physiological status of their parent cells. sEVs are also widely distributed in body fluids, which helps overcome the problem of inaccessibility in sample or specimen collection in some cases. Furthermore, the composition of sEVs can be used as diagnostic biomarkers for several disease conditions, including oral mucosal diseases. This review critically examines the emerging role of sEVs-derived biomarkers from saliva and blood in the diagnosis of some oral mucosal diseases, such as hand, foot, and mouth disease (HFMD), oral lichen planus (OLP), oral leukoplakia (OL), and oral squamous cell carcinoma (OSCC). It also discusses the need for the validation and standardization of the potential sEV-derived diagnostic biomarkers of these oral mucosal diseases for clinical application.
- 30 March 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (7) , 1044
Open AccessClinical Utility of Small Extracellular Vesicles as Liquid Biopsy for Oral Mucosal Disease Diagnostics: Emerging Perspectives
Some diseases affecting the oral mucosa can be life-threatening and/or associated with life-threatening complications. Conventional diagnostic methods for most oral mucosal diseases are usually employed at a fully established disease state. All these peculiarities usually result in late diagnosis, poor prognosis, poor treatment outcomes, and reduced overall survival rates, hence the need for novel methods for the early detection of these disease conditions. Small extracellular vesicle (sEV)-based diagnosis carries great potential for early diagnosis of oral mucosal diseases, as sEVs reflect the physiological status of their parent cells. sEVs are also widely distributed in body fluids, which helps overcome the problem of inaccessibility in sample or specimen collection in some cases. Furthermore, the composition of sEVs can be used as diagnostic biomarkers for several disease conditions, including oral mucosal diseases. This review critically examines the emerging role of sEVs-derived biomarkers from saliva and blood in the diagnosis of some oral mucosal diseases, such as hand, foot, and mouth disease (HFMD), oral lichen planus (OLP), oral leukoplakia (OL), and oral squamous cell carcinoma (OSCC). It also discusses the need for the validation and standardization of the potential sEV-derived diagnostic biomarkers of these oral mucosal diseases for clinical application.
- 16 June 2021
- Published by Taylor & Francis in Traffic Injury Prevention
- Vol. 22 (6) , 425-430
Nigerian law enforcement agents’ knowledge and enforcement of drink-drive law
To understand how knowledgeable and equipped the law enforcement agents in Nigeria are to enforce the drink-drive law.We conducted a descriptive cross-sectional study of Law Enforcement Agents in f...
- 16 June 2021
- Published by Taylor & Francis in Traffic Injury Prevention
- Vol. 22 (6) , 425-430
Nigerian law enforcement agents’ knowledge and enforcement of drink-drive law
To understand how knowledgeable and equipped the law enforcement agents in Nigeria are to enforce the drink-drive law.We conducted a descriptive cross-sectional study of Law Enforcement Agents in f...